Moneypox Outbreak Puts Focus On These Two Biotechs

Scott365

Published on: 31/05/2022

Just when you thought it was safe to go outside, monkeypox pops up. With the potential for even more global cases, keep an eye on these vaccine stocks.

Biotechsmonkeypoxvaccine makersVaccine StocksBiopharma StocksBiotech InvestmentsBiotech StocksPharmaceutical StocksStocks to Watch

Sympathy Moves On Biogen’s Big News

Ashley Hayes

Published on: 21/06/2021

Big news for one stock can result in sympathy moves for other stocks. So, in the wake of big news for Biogen with the FDA approval of its Alzheimer’s drug

Alzheimer's StocksBiogenFDA ApprovalInvestingStock Market2021 Stock PicksBiopharma StocksBiotech InvestmentsBiotech StocksInvestInvestingInvestment StrategiesInvestors

A Defiant ETF Bet

Ashley Hayes

Published on: 30/03/2021

Biotech stocks have been retreating, as have small-cap stocks. But this ETF at the intersection of both could still be a great bet. CLICK HERE.

Biotech StocksEFTEFT BetInvestment PortfolioSmall-Cap StocksStock Market2021 Stock PicksBiopharma StocksBiotech InvestmentsBiotech StocksETFsExchange-Traded FundsInvestInvestingInvestment Strategies

2 Clinical-Stage Biopharma Stocks With Triple-Digit Upside Potential

Ashley Hayes

Published on: 20/09/2020

Analysts at Wells Fargo – and the broader analyst community – see triple-digit upside potential in these two stocks, both clinical-stage biopharmaceutical

Biopharma StocksInvestingStock MarketWells Fargo2020 Stock PicksBiopharma StocksStock MarketStocks to Watch